Tag Archives: gene therapy

Optum Frontier Therapies Launched to Focus on Cell and Gene Therapy

Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics

PantherRx Rare and Orsini Specialty Pharmacy Chosen as Partners for OXLUMO

Alnylam® Pharmaceuticals selected PantherRx Rare and Orsini Specialty Pharmacy as limited distribution partners for OXLUMO™ (lumasiran). OXLUMO is the first and only treatment approved for primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare genetic disease characterized by the overproduction of oxalate, a waste product that […]

CareMetx, LLC’s OutcomeRx Launches a Reinsurance Product for Cell and Gene Therapies

OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs